Core Points - The chairman and actual controller of the company, Yin Zhenglong, passed away on August 26, 2025, at the age of 60 [1][3] - Yin Zhenglong was the founder of the company and held 63,057,454 shares, accounting for 26.90% of the total shares, making him the controlling shareholder [3] - Following his passing, the board of directors appointed Song Daocai, a director and general manager, to temporarily assume the roles of chairman and legal representative until a new chairman is elected [3] - The company specializes in the research, production, and sales of pharmaceutical excipients, including fillers, adhesives, disintegrants, lubricants, and coating materials for oral solid dosage forms [3] - The company's official website turned black and white on August 27, 2025, in tribute to the deceased chairman [3]

Core Points - The chairman and actual controller of the company, Yin Zhenglong, passed away on August 26, 2025, at the age of 60 [1][3] - Yin Zhenglong was the founder of the company and had held key positions since its establishment, including chairman and general manager [3] - He owned 63.0575 million shares, accounting for 26.9% of the total shares, making him the controlling shareholder [3] - The company will handle the transfer of shares according to relevant laws and regulations and will disclose information as necessary [3] - The board of directors has appointed Song Daocai, a director and general manager, to temporarily assume the roles of chairman and legal representative until a new chairman is elected [3] - The company specializes in the research, production, and sales of pharmaceutical excipients, including fillers, adhesives, disintegrants, lubricants, and coating materials for oral solid dosage forms [3] - As of August 26, 2025, the company's stock price was 14.34 yuan per share, with a total market capitalization of 3.4 billion yuan [3] - The number of shareholders as of June 30, 2025, was 17,500 [3]

Core Viewpoint - The announcement of the passing of Yin Zhenglong, the controlling shareholder and chairman of Anhui Shanhe Pharmaceutical Excipients Co., Ltd., marks a significant event for the company, as he was instrumental in its development and growth [5][6]. Group 1: Company Overview - Anhui Shanhe Pharmaceutical Excipients Co., Ltd. specializes in the research, production, and sales of pharmaceutical excipients, including fillers, binders, disintegrants, lubricants, and coating materials [3]. - As of August 26, 2025, the company's stock price was reported at 14.34 yuan per share, with a total market capitalization of 3.4 billion yuan [4]. Group 2: Leadership Transition - Following the death of Yin Zhenglong, the company will not experience a reduction in the number of board members below the legal requirement, and the management team will continue to operate normally [7]. - Song Daocai, the current general manager, has been appointed to temporarily assume the responsibilities of chairman and legal representative until a new chairman is elected [7].

Core Viewpoint - The passing of Yin Zhenglong, the controlling shareholder and chairman of Shanhe Pharmaceutical Auxiliary, marks a significant loss for the company and the industry, as he dedicated his life to the development of China's pharmaceutical sector and the company's growth [1][3]. Company Overview - Shanhe Pharmaceutical Auxiliary focuses on the research, production, and sales of pharmaceutical excipients, including fillers, adhesives, disintegrants, lubricants, and coating materials for oral solid dosage forms [4]. - As of August 26, the company's stock price was 14.34 yuan per share, with a total market capitalization of 3.4 billion yuan [4]. - The number of shareholders as of June 30, 2025, was 17,500 [4]. Leadership Transition - Following Yin Zhenglong's death, the company confirmed that the board of directors would remain operational, and the management team would continue its duties without disruption [4]. - The position of chairman is currently vacant, and the company will expedite the election of a new chairman in accordance with relevant laws and regulations [4]. - Until a new chairman is elected, the current director and general manager, Song Daocai, will temporarily assume the responsibilities of chairman and legal representative [4]. Contributions and Legacy - Yin Zhenglong was instrumental in transforming Shanhe Pharmaceutical Auxiliary from a local pharmaceutical factory into a publicly listed company on the Shenzhen Stock Exchange, contributing significantly to the domestic pharmaceutical excipient industry [3]. - His leadership and dedication earned him deep respect and affection from employees, and the company expressed heartfelt condolences to his family [3].

Core Viewpoint - The passing of Yin Zhenglong, the controlling shareholder and chairman of Shanhe Pharmaceutical Auxiliary, marks a significant loss for the company and the industry, as he dedicated his life to the development of China's pharmaceutical sector and the advancement of domestic pharmaceutical excipients [1][3]. Company Overview - Shanhe Pharmaceutical Auxiliary focuses on the research, production, and sales of pharmaceutical excipients, including fillers, adhesives, disintegrants, lubricants, and coating materials for oral solid dosage forms [5]. - As of August 26, 2025, the company's stock price was 14.34 yuan per share, with a total market capitalization of 3.4 billion yuan [5]. - The number of shareholders as of June 30, 2025, was 17,500 [5]. Leadership Transition - Following Yin Zhenglong's death, the company confirmed that the board of directors would remain operational and that the management team would continue to perform their duties without disruption [4]. - The company will conduct a board member election and appoint a new chairman in accordance with relevant laws and regulations. In the interim, Song Daocai, a current board member and general manager, will assume the responsibilities of chairman and legal representative [5].